| Literature DB >> 30621313 |
Juan José Hernández Morante1, Carmelo Gómez Martínez2,3, Juana María Morillas-Ruiz4.
Abstract
Frailty syndrome is a medical condition that is characterised by a functional decline, usually from 65 years old on, and creates the need for assistance to perform daily living activities. As the population ages, the need for specialised geriatric care will increase immensely, and consequently, the need for specialised services for the care of these people will increase accordingly. From a nutritional point of view, to control or balance the nutritional status of residents will be essential in order to prevent sarcopenia and, consequently, frailty development. In this line, previous studies have highlighted the association among low energy intake, inadequate intake of protein and vitamin D, and an increased risk of frailty development. However, there is a lack of intervention studies on frail patients, especially in the realm of quality clinical trials. The few studies performed to date seem to indicate that there is a protective role of protein supplementation against frailty syndrome. In this regard, it is tempting to suggest daily 30 g protein supplements to prevent frailty. However, it is well established that excess protein can also be harmful; therefore, specific individual characteristics should be considered before prescribing these supplements. On the other hand, the relevance of other nutritional interventions, such as vitamin D, omega-3, and medium-chain triglycerides, is much more scarce in the literature. Therefore, we encourage the development of new clinical trials to carry out effective therapies to prevent frailty development.Entities:
Keywords: frailty; nursing home; omega-3; protein supplementation; vitamin D
Mesh:
Substances:
Year: 2019 PMID: 30621313 PMCID: PMC6356476 DOI: 10.3390/nu11010102
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Frailty development cycle, adapted from Fried et al. [3] and possible nutritional targets to prevent frailty development. EPA: Eicosapentaenoic acid, DHA: Docosahexaenoic acid.
Summary of clinical trials performed to evaluate the effect of protein supplementation on frailty syndrome.
| Reference | Population and Study Design | Age Range * | Intervention | Outcome Measure | Results |
|---|---|---|---|---|---|
| Kim et al. 2013 [ | 79 ± 6 | Two 200-mL liquid formula (400 kcal, 25 g of protein, 9.4 g of essential amino acids, 400 mL of water) per day for 12 weeks | Change of the physical functioning and SPPB | Physical functioning increased by 5.9% in the intervention group | |
| Porter Starr et al. 2016 [ | 68 ± 5 | Regimen with higher protein intake (>30 g) at each meal | Physical function and lean mass | The increase in the protein content was greater than in the control ( | |
| Collins et al. 2016 [ | 70 ± 5 | Whey protein and creatine co-supplementation or whey protein supplementation | Muscle function and body composition | Both groups were similarly effective in improving muscle function | |
| Fernandes et al. 2017 [ | ND | Isolated leucine supplementation (study 1); protein source (whey vs. soy–study 2); combination of whey protein and creatine (study 3) | Muscle cross-sectional area, fibre cross-sectional area, body composition | Not finished yet | |
| Niccoli et al. 2017 [ | 82 ± 2 | An oral dietary product containing 24 g of whey protein per day in addition to their usual diet | Frailty criteria | Whey protein significantly increases grip strength | |
| Dirks et al. 2017 [ | 77 ± 1 | 6-month progressive resistance-type exercise training supplemented with milk protein (2 × 15 g/day) | Type I and type II muscle fibre specific cross-sectional area | Protein supplementation augmented muscle fibre hypertrophy following prolonged resistance-type exercise training in frail older people | |
| Vojciechowski et al. 2018 [ | A randomised controlled clinical trial with a sample of pre-frail older women ( | ND | Physical training combined with protein supplementation | Strength and power of the lower limbs and body composition | Not finished yet |
* Age was described as mean age ± sd. ND: Not determined. SPPB: Short-form health survey.
Summary of the other clinical trials performed to evaluate the effect of nutrient supplementation or dietary interventions on frailty syndrome (protein supplement trials are summarised in Table 1).
| Reference | Population and Study Design | Age Range * | Intervention | Outcome Measure | Results |
|---|---|---|---|---|---|
| Latham et al. 2003 [ | 79 ± 2 | Single dose of vitamin D (calciferol, 300,000 IU) | Physical health according to the short-form health survey (SPPB) | There was no effect of either intervention on physical health or falls | |
| Boxer et al. 2013 [ | 66 ± 10 | Weekly | The primary outcome was peak oxygen uptake | Vitamin D3 did not improve physical performance | |
| Bauer et al. 2015 [ | n = 380; Multicenter, randomized, controlled, double-blind, 2 parallel-group trial | 77 ± 7 | A vitamin D and leucine-enriched whey protein nutritional supplement | Handgrip strength and SPPB score | Improvements in muscle mass among sarcopenic older adults |
| Hutchins-Wiese et al. 2013 [ | 75 ± 6 | 2 fish oil (1.2 g eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)) or 2 placebo (olive oil) capsules | Frailty assessment | Physical performance was significantly improved by fish oil supplementation | |
| Strike et al. 2016 [ | ND | 1g DHA, 160 mg eicosapentaenoic acid, 240 mg Ginkgo biloba, 60 mg phosphatidylserine, 20 mg d-α tocopherol, 1mg folic acid, and 20 µg vitamin B12 | Mobility assessed motion capture camera system | Multinutrient supplementation improved mobility in older females | |
| Ng et al. 2015 [ | 70 ± 5 | Combined nutritional supplement (iron, folate, vitamin B6, vitamin B12, vitamin D and calcium | Frailty status | Frailty index score was significantly improved in subjects supplemented with the combined nutritional supplement | |
| Badrasawi et al. 2016 [ | 68 ± 6 | L-carnitine | Frailty status | Frailty index score was significantly improved in subjects supplemented with L-carnitine | |
| Wu et al. 2018 [ | 73 ± 2 | Multiple micronutrient supplements, multiple micronutrients plus isolated soy protein supplements and individualised nutrition education | Frailty score | Only individualised nutrition education decreases frailty score | |
| Chan et al. 2012 [ | 71 ± 4 | Exercise and nutrition (EN) or problem-solving therapy | Cardiovascular health study phenotypic classification of frailty | EN intervention resulted in short-term frailty status improvement |
* Age was described as mean age ± sd. ND: Not determined.